These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26239979)

  • 61. Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay.
    Kumar M; Khan IA; Verma V; Kalyan N; Qazi GN
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):121-4. PubMed ID: 16168616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel red fluorescence protein based microplate assay for drug screening against dormant Mycobacterium tuberculosis by using paraffin.
    Yeware A; Sarkar D
    Tuberculosis (Edinb); 2018 May; 110():15-19. PubMed ID: 29779767
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacology.
    Sutherland HS; Tong AST; Choi PJ; Blaser A; Franzblau SG; Cooper CB; Upton AM; Lotlikar M; Denny WA; Palmer BD
    Bioorg Med Chem; 2020 Jan; 28(1):115213. PubMed ID: 31810890
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity.
    Sarathy JP; Ragunathan P; Cooper CB; Upton AM; Grüber G; Dick T
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.
    Tyagi S; Nuermberger E; Yoshimatsu T; Williams K; Rosenthal I; Lounis N; Bishai W; Grosset J
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2289-93. PubMed ID: 15917523
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating
    Lopez Quezada L; Li K; McDonald SL; Nguyen Q; Perkowski AJ; Pharr CW; Gold B; Roberts J; McAulay K; Saito K; Somersan Karakaya S; Javidnia PE; Porras de Francisco E; Amieva MM; Dı Az SP; Mendoza Losana A; Zimmerman M; Liang HH; Zhang J; Dartois V; Sans S; Lagrange S; Goullieux L; Roubert C; Nathan C; Aubé J
    ACS Infect Dis; 2019 Aug; 5(8):1433-1445. PubMed ID: 31184461
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2015; 1285():293-315. PubMed ID: 25779324
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.
    Speer A; Shrestha TB; Bossmann SH; Basaraba RJ; Harber GJ; Michalek SM; Niederweis M; Kutsch O; Wolschendorf F
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1089-91. PubMed ID: 23254420
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro antimycobacterial activity of six Cameroonian medicinal plants using microplate alamarBlue assay.
    Nkenfou CN; Mawabo IK; Notedji A; Nkenfou J; Fokou PV; Jouda JB; Kuiate JR
    Int J Mycobacteriol; 2015 Dec; 4(4):306-11. PubMed ID: 26964813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics.
    Machado D; Azzali E; Couto I; Costantino G; Pieroni M; Viveiros M
    Future Microbiol; 2018 Sep; 13():1383-1402. PubMed ID: 30259757
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
    Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
    Diacon AH; Dawson R; von Groote-Bidlingmaier F; Symons G; Venter A; Donald PR; van Niekerk C; Everitt D; Winter H; Becker P; Mendel CM; Spigelman MK
    Lancet; 2012 Sep; 380(9846):986-93. PubMed ID: 22828481
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis.
    Dixit P; Singh U; Sharma P; Jain A
    J Microbiol Methods; 2012 Jan; 88(1):122-6. PubMed ID: 22133919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum.
    Sarathy JP; Via LE; Weiner D; Blanc L; Boshoff H; Eugenin EA; Barry CE; Dartois VA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
    Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
    Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis.
    Li SY; Tasneen R; Tyagi S; Soni H; Converse PJ; Mdluli K; Nuermberger EL
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630203
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis.
    Chen C; Gardete S; Jansen RS; Shetty A; Dick T; Rhee KY; Dartois V
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463541
    [No Abstract]   [Full Text] [Related]  

  • 80. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.